- Home
- HFFG vs PBYI Comparison
HFFG vs PBYI Comparison
Compare HFFG & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- PBYI
- Stock Information
- Founded
- HFFG N/A
- PBYI 2010
- Country
- HFFG United States
- PBYI United States
- Employees
- HFFG N/A
- PBYI N/A
- Industry
- HFFG Food Distributors
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- HFFG Consumer Discretionary
- PBYI Health Care
- Exchange
- HFFG Nasdaq
- PBYI Nasdaq
- Market Cap
- HFFG 165.0M
- PBYI 176.1M
- IPO Year
- HFFG N/A
- PBYI N/A
- Fundamental
- Price
- HFFG $3.08
- PBYI $2.25
- Analyst Decision
- HFFG
- PBYI Strong Buy
- Analyst Count
- HFFG 0
- PBYI 1
- Target Price
- HFFG N/A
- PBYI $7.00
- AVG Volume (30 Days)
- HFFG 36.7K
- PBYI 393.7K
- Earning Date
- HFFG 08-06-2024
- PBYI 10-31-2024
- Dividend Yield
- HFFG N/A
- PBYI N/A
- EPS Growth
- HFFG N/A
- PBYI N/A
- EPS
- HFFG 0.07
- PBYI 0.18
- Revenue
- HFFG $1,160,322,000.00
- PBYI $219,143,000.00
- Revenue This Year
- HFFG N/A
- PBYI N/A
- Revenue Next Year
- HFFG N/A
- PBYI N/A
- P/E Ratio
- HFFG $41.59
- PBYI $12.36
- Revenue Growth
- HFFG N/A
- PBYI N/A
- 52 Week Low
- HFFG $2.46
- PBYI $2.13
- 52 Week High
- HFFG $5.91
- PBYI $7.73
- Technical
- Relative Strength Index (RSI)
- HFFG 44.57
- PBYI 31.78
- Support Level
- HFFG $3.18
- PBYI $2.42
- Resistance Level
- HFFG $3.56
- PBYI $2.56
- Average True Range (ATR)
- HFFG 0.22
- PBYI 0.17
- MACD
- HFFG -0.02
- PBYI -0.02
- Stochastic Oscillator
- HFFG 6.35
- PBYI 3.88
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.